Denali Therapeutics Inc. DNLI
18.45 USD +0.25 (+1.37%)
Regular-session close
18.45 0.00 0.00%
After hours · Nov 20, 4:52 PM ET
17.92 Day range 18.85
16.02 52-week range 27.21
- YTD
- +11.75%
- 1 year
- +7.52%
DNLI revenue history
Revenue is income from the company’s ordinary business activities.
0 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 0 | 0 | Not meaningful |
| FY 2024 | 2024-12-31 | 0 | -330,531,000 | -100.00% |
| FY 2023 | 2023-12-31 | 330,531,000 | 222,068,000 | 204.74% |
| FY 2022 | 2022-12-31 | 108,463,000 | 59,802,000 | 122.90% |
| FY 2021 | 2021-12-31 | 48,661,000 | -286,998,000 | -85.50% |
| FY 2020 | 2020-12-31 | 335,659,000 | 308,981,000 | 1158.19% |
| FY 2019 | 2019-12-31 | 26,678,000 | -102,482,000 | -79.34% |
| FY 2018 | 2018-12-31 | 129,160,000 | 129,160,000 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | 0 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | 0 | Not meaningful |
| FY 2015 | 2015-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-09T06:02:03.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
